Pneumocystis pneumonia in everolimus therapy: An indistinguishable case from drug induced interstitial lung disease

Abstract

A 66-year-old male treated with everolimus for renal cell carcinoma developed exertional dyspnea. Chest computed tomography revealed diffuse interstitial shadows on both lungs. Bronchoalveolar lavage and the drug-induced lymphocyte stimulation test confirmed the diagnosis of drug-induced interstitial lung disease due to everolimus therapy. However… (More)
DOI: 10.1016/j.rmcr.2013.07.003

Topics

3 Figures and Tables

Slides referencing similar topics